Vanguard Group »

Tscan Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 2.1M 5.85
2024-03-31 $14M 1.8M 7.94
2023-12-31 $10M 1.8M 5.83
2023-09-30 $4.5M 1.8M 2.56
2023-06-30 $3.4M 1.4M 2.50
2023-03-31 $623k 297k 2.10
2022-12-31 $412k 266k 1.55
2022-06-30 $711k 226k 3.14
2022-03-31 $636k 227k 2.80
2021-09-30 $3.7M 445k 8.34